Related Experiment Video
Updated: Apr 16, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Cytomegalovirus polyradiculopathy in three Japanese patients with AIDS
Kazuaki Kameda1, Michinori Shirano, Yoshiro Hadano
1Department of Infectious Diseases, Osaka City General Hospital, Japan.
Abstract:
Polyradiculopathy (PRP) is a rare but serious neurologic complication of cytomegalovirus (CMV) in patients with acquired immunodeficiency syndrome (AIDS). We herein report three cases of CMV PRP in patients with AIDS. Although providing a prompt diagnosis and initiating anti-CMV therapy may achieve clinical improvements, administering single-drug treatment may result in virologic failure. Therefore, introducing antiretroviral therapy is a key step for improving the treatment outcomes of CMV PRP.
Insights
Cytomegalovirus (CMV) polyradiculopathy (PRP) is a serious complication in acquired immunodeficiency syndrome (AIDS). Combination therapy, including antiretroviral treatment, is crucial for managing CMV PRP and preventing treatment failure.
Area of Science:
- Neurology
- Infectious Diseases
- Virology
Background:
- Cytomegalovirus (CMV) infection is a significant concern in individuals with acquired immunodeficiency syndrome (AIDS).
- CMV can lead to rare but severe neurological complications, such as polyradiculopathy (PRP).
Observation:
- This report details three cases of CMV-associated polyradiculopathy (PRP) in patients diagnosed with AIDS.
- The observed cases highlight the critical neurological manifestations of CMV in this patient population.
Findings:
- Prompt diagnosis and initiation of anti-CMV therapy can lead to clinical improvement.
- However, monotherapy for CMV PRP may result in virologic failure.
- The introduction of effective antiretroviral therapy (ART) is essential for successful treatment outcomes.
Implications:
- Effective management of CMV PRP in AIDS patients requires a multi-faceted therapeutic approach.
- Integrating antiretroviral therapy alongside anti-CMV treatment is vital for preventing treatment failure and improving patient prognosis.
- Further research into optimal treatment strategies for opportunistic infections in immunocompromised individuals is warranted.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Arboviral Encephalitis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Viral Meningitis

